Groupama Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.16M Sell
14,303
-657
-4% -$225K 0.07% 106
2026
Q1
$5.26M Buy
14,960
+2,576
+21% +$918K 0.08% 102
2025
Q4
$4.05M Buy
12,384
+22
+0.2% +$6.98K 0.06% 115
2025
Q3
$3.49M Sell
12,362
-1,401
-10% -$406K 0.05% 130
2025
Q2
$3.81M Sell
13,763
-2,736
-17% -$775K 0.06% 131
2025
Q1
$5.06M Sell
16,499
-981
-6% -$290K 0.1% 102
2024
Q4
$4.53M Sell
17,480
-3,054
-15% -$906K 0.09% 119
2024
Q3
$5.31M Sell
20,534
-1,011
-5% -$331K 0.14% 104
2024
Q2
$6.73M Buy
21,545
+6,047
+39% +$1.78M 0.09% 116
2024
Q1
$6.74M Sell
15,498
-22,526
-59% -$6.59M 0.12% 119
2023
Q4
$11M Buy
+38,024
New +$10.4M 0.29% 66

Other funds holding AMGN

Groupama Asset Management's AMGN Position: Q2 2026 in Review

Groupama Asset Management reduced its Amgen (AMGN) stake by 4.4% in Q2 2026, selling an estimated $225K and leaving 14,303 shares worth $5.16M. The position accounts for 0.07% of the portfolio, ranked #106.

Groupama Asset Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $11M in Q4 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Groupama Asset Management held 14,303 shares of Amgen worth $5.16M as of Q2 2026.
  • Groupama Asset Management sold 657 Amgen shares in Q2 2026, an estimated $225K.
  • Amgen made up 0.07% of Groupama Asset Management's portfolio in Q2 2026, its #106 holding.
  • Groupama Asset Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Groupama Asset Management's Amgen position peaked at $11M in Q4 2023.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.